Zolbetuximab is a targeted therapeutic drug against CLDN18.2, which plays a crucial role in the treatment of unresectable, advanced, and recurrent gastric cancer positive for Claudin18.2. Its unique therapeutic effect has brought new hope for treatment to patients. However, up to now, although zolbetuximab has been launched in China, it has not been included in the national medical insurance list. Patients can purchase it through channels such as hospitals, overseas drug procurement, and cross-border e-commerce platforms.
How to Purchase Zolbetuximab
Zolbetuximab has been officially launched in China, and patients can obtain the drug through multiple channels.
Overseas Drug Procurement
For patients in urgent need of zolbetuximab, overseas drug procurement is an option. Patients can purchase the drug through foreign pharmacies, medical institutions, or professional drug-purchasing services. However, overseas drug procurement involves many risks, such as unguaranteed drug quality and restrictions from laws and regulations. It is recommended that patients choose reputable channels and consult professional medical personnel to ensure the safety of drug procurement.
Participation in Clinical Trials
Another way to obtain zolbetuximab is to participate in clinical trials. Patients can get the drug by joining relevant clinical trials. Clinical trials not only provide patients with treatment opportunities but also help collect data on the safety and efficacy of the drug.
Drug Interactions of Zolbetuximab
Understanding the drug interactions of zolbetuximab is essential to ensure the safe use of the drug by patients.
No Clinical Studies Conducted Yet
Clinical studies on the interactions between zolbetuximab and other drugs have not been conducted yet. When using zolbetuximab, patients should be cautious and avoid using it simultaneously with other drugs to prevent adverse reactions. If combined drug use is necessary, it should be carried out under the guidance of professional medical personnel, and the patient's physical condition should be closely monitored.
Attention to Potential Risks
Zolbetuximab is a monoclonal antibody drug, and there may be potential risks of interactions with other drugs. During the medication period, patients should pay attention to observing their physical condition. If any discomfort symptoms occur, they should seek medical attention in a timely manner. Patients should also inform doctors of other drugs they are using in a timely manner, so that doctors can assess the potential risk of drug interactions.
How to Store Zolbetuximab
Proper storage methods are conducive to maintaining the quality and efficacy of zolbetuximab.
Storage Conditions
Zolbetuximab should be stored at a temperature of 2-8°C. This temperature range helps maintain the stability and activity of the drug. Patients should store the drug in a cool, dry, and well-ventilated place, avoiding direct sunlight and high-temperature environments. They should also regularly check the storage conditions of the drug to ensure it is kept in a suitable storage environment.
Precautions
Avoid exposing the drug to humid environments to prevent it from getting damp and deteriorating.
Do not store the drug together with other medicines or items to avoid cross-contamination.
Patients should store the drug in accordance with the doctor's instructions and the requirements in the drug instruction manual, and should not arbitrarily change the storage conditions or usage methods.
For long-term storage, patients should also consider using refrigeration equipment and regularly monitor the storage temperature.
In addition, patients should make medication decisions and monitor their physical condition under the guidance of professional medical personnel.
